Welcome to our dedicated page for Ionq SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Quantum computing promises transformative returns, yet IonQ’s SEC documents can read like a physics dissertation. Locating R&D burn rates, deciphering option grants, or spotting dilution warnings inside a single IonQ annual report 10-K simplified often takes hours. Stock Titan eliminates that pain. Our AI delivers IonQ SEC filings explained simply, showing the numbers and milestones without the math PhD.
Every time IonQ hits the EDGAR tape, we post the filing within seconds and pair it with machine-written context. Need the next IonQ quarterly earnings report 10-Q filing or an IonQ 8-K material events explained? It’s already summarized. Want alerts the moment a director sells shares? Our feed of IonQ Form 4 insider transactions real-time keeps you ahead. Below you’ll find:
- 10-K & 10-Q breakdowns highlighting cash runway, government contract backlog, and qubit roadmaps.
- Form 4 dashboards for IonQ insider trading Form 4 transactions and IonQ executive stock transactions Form 4.
- Proxy statement insights detailing IonQ proxy statement executive compensation.
- Instant notes on 8-K releases, mergers, or financing updates.
Use these AI summaries to compare quarter-over-quarter progress, monitor insider sentiment, or share concise takeaways with clients. Whether you’re modeling cash needs or validating strategic milestones, understanding IonQ SEC documents with AI turns dense disclosures into actionable clarity. Save time, catch details others miss, and rely on our IonQ earnings report filing analysis to stay informed about the company pushing quantum boundaries.
IonQ director William J. Teuber Jr. was granted 4,413 restricted stock units (RSUs) on 08/26/2025 as compensation. The RSUs carry a $0 grant price and will vest in full on the earlier of the 2026 Annual Meeting (or immediately prior if his board service ends) or June 18, 2026, provided he continues to serve on the board through the vesting date. The Form 4 reports the transaction as a direct beneficial ownership change and is filed for one reporting person.
IonQ director Jim Frankola received a grant of 4,413 restricted stock units (RSUs) on 08/26/2025. The RSUs were reported on a Form 4 and are scheduled to vest in full on the earlier of the company’s 2026 Annual Meeting (or immediately prior if his board service ends) or June 18, 2026, but only if he remains a board member through the vesting date. The grant was reported as a zero-price award, consistent with typical director compensation in the form of equity awards. The Form 4 was executed by an attorney-in-fact on 08/28/2025.
IonQ, Inc. prospectus supplement (Form 424B7) describes registration of shares by selling stockholders and methods for secondary sales, including over-the-counter, privately negotiated or exchange transactions, and refers readers to the Plan of Distribution on page S-13 for details. The document states that directors and officers are not subject to lock-up agreements and therefore, subject to securities laws, may sell shares at any time after September 5, 2025. It incorporates prior SEC filings by reference, including a Form 10-Q for the quarter ended June 30, 2025 filed on August 6, 2025, a 10-K filed February 26, 2025, and an 8-A filed November 10, 2020. The supplement references the company’s QCaaS offering and lists the corporate website https://ionq.com (website content not part of the prospectus).
Insider transactions by Director Inder M. Singh at IonQ (IONQ)
On 08/13/2025 Inder M. Singh executed multiple option-related transactions and a sale. He acquired 33,570 shares at $12.93, 2,050 shares at $5.72, and 14,860 shares at $13.53 through option-related actions. On the same date he sold 50,480 shares at a weighted-average price of $43.023. After these transactions the report shows the Reporting Person beneficially owned 5,513 shares. The filing notes all option shares were fully vested and exercisable as of the transaction date and that the sale price range was $42.97 to $43.16.
IonQ reported executive compensation changes affecting its Chief Executive Officer, Niccolo de Masi. The filing states Mr. de Masi was granted 485,319 RSUs effective August 13, 2025, which vest quarterly over three years, and his annual base salary was increased to $700,000. The filing also references performance share units (PSUs) in relation to the structure held by other senior employees and internal pay equity, noting strong performance and strategy initiatives as context for the awards.
IonQ director and CEO received a restricted stock unit award totaling 485,319 shares that vests over three years with quarterly vesting on March 10, June 10, September 10 and December 10, contingent on continued service. Following this grant the reporting person beneficially owns 1,197,306 shares. The award is reported as acquired at a $0 price because it is an RSU grant rather than a purchase. The filing documents the grant date and vesting schedule but does not include performance-based conditions; vesting is tied to continued service through each vesting date.